NATERA, INC. Operating Lease Liability
NATERA, INC. (NTRA) had Operating Lease Liability of $158.20 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability $158.20M.
- 2026-03-31: Operating Lease, Liability $159.78M.
- 2025-12-31: Operating Lease, Liability $134.05M.
- 2025-09-30: Operating Lease, Liability $118.39M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $158.20M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $159.78M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $134.05M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $118.39M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $115.80M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $115.25M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $106.76M 10-K · filed 2026-02-27 |
| 2024-09-30 | $108.72M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $73.61M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $76.12M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $78.65M 10-K · filed 2025-02-28 |
| 2023-09-30 | $79.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $81.53M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $83.16M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $84.22M 10-K · filed 2024-02-29 |
| 2022-09-30 | $84.61M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $71.05M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $72.72M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $66.79M 10-Q · filed 2022-11-09 |
| 2021-09-30 | $55.31M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $55.85M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $56.86M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $28.55M 10-K · filed 2021-02-26 |
| 2020-09-30 | $27.82M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $29.27M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $30.67M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $32.04M 10-K · filed 2020-03-02 |
| 2019-09-30 | $33.36M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $34.61M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $35.82M 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |